Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Short term Debt (2016 - 2025)

Dare Bioscience's Short term Debt history spans 8 years, with the latest figure at $10542.0 for Q3 2025.

  • For Q3 2025, Short term Debt changed N/A year-over-year to $10542.0; the TTM value through Sep 2025 reached $10542.0, changed N/A, while the annual FY2024 figure was $4054.0, N/A changed from the prior year.
  • Short term Debt reached $10542.0 in Q3 2025 per DARE's latest filing, down from $187966.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.0 million in Q1 2021 to a low of $4054.0 in Q4 2024.
  • Average Short term Debt over 3 years is $382411.5, with a median of $139936.5 recorded in 2025.